在免疫检查点阻塞下,模拟组合疗法和T细胞枯竭动态在瘤中的免疫检查点阻塞
1School of Mathematics, Renmin University of China, Beijing, P. R. China. xiulanlai@ruc.edu.cn.
Bulletin of mathematical biology
|August 11, 2025
概括
瘤CD8+T细胞耗尽阻碍了免疫检查点的阻塞. 数学建模表明,晚期疲劳导致免疫逃脱,但新的组合疗法可以改善瘤控制.
科学领域:
- 免疫学 免疫学 免疫学
- 数学生物学 数学生物学
- 计算瘤学计算瘤学
背景情况:
- 长期暴露于瘤中的抗原会导致CD8+T细胞疲劳,其特征是抑制受体增加和效应器功能减少.
- 免疫检查点封锁 (ICB) 旨在逆转T细胞枯竭,但其有效性取决于瘤透T细胞的初始状态.
研究的目的:
- 开发一种数学模型,研究T细胞枯竭如何影响瘤免疫平衡.
- 分析抗PD-L1治疗在不同T细胞耗尽水平的疗效.
- 评估下一代疗法的潜力,如IFNα-anti-PD-L1和PD1-IL2v,克服T细胞耗尽并增强抗瘤免疫力.
主要方法:
- 开发一个数学模型来模拟瘤免疫动态.
- 稳定性分析以了解瘤免疫系统的平衡状态.
- 在模拟中评估T细胞耗尽对抗PD-L1疗效和新型组合疗法的影响.
主要成果:
- 瘤PD-L1表达显著影响免疫力学,影响无瘤和瘤状态的稳定性.
- 高的PD-1表达和耗尽率与瘤生长和较少耗尽的CD8+ T细胞扩张的减少有关.
- 抗PD-L1疗效取决于基线疲劳水平,严重的疲劳导致免疫逃逸.
结论:
- 数学建模提供了T细胞枯竭和抗瘤免疫之间的复杂相互作用的见解.
- 严重的T细胞枯竭对ICB疗效构成重大障碍,可能导致免疫逃脱.
- 增强T细胞细胞毒性并维持较少耗尽的T细胞种群的下一代疗法证明了瘤控制的改善,突出显示了组合策略的承诺.
相关概念视频
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:22T Cell Activation and Clonal Selection
4.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.6K